Market Overview:
The global stem cell concentration system market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The market growth can be attributed to factors such as rising prevalence of chronic diseases, increasing number of stem cell therapies being approved by regulatory authorities, and growing investments in regenerative medicine. Based on type, the global stem cell concentration system market is segmented into syringes, bone marrow collection needles, anticoagulant and concentrating devices, and others. The syringes segment is expected to account for the largest share of the market in 2018 owing to their low cost and easy availability. Based on application, the hospital segment is expected to account for the largest share of the market in 2018 owing to rising demand for stem cell therapies from hospitals worldwide. Geographically, North America dominates the global stem cell concentration system market followed by Europe due with a significant contribution from countries such as U.S.
Product Definition:
A stem cell concentration system is a device used to isolate and concentrate stem cells from other cell types in a sample. The importance of stem cell concentration systems is that they allow for the efficient separation and isolation of stem cells, which can then be used for research or therapeutic purposes.
Syringes:
A syringe is a hollow cylindrical container, used for the transfer of fluids. It can be made from almost all materials including plastic, glass and metal. The most commonly used material for manufacturing syringes is stainless steel due to its high resistance towards chemicals and temperature.
The stem cell concentration system market size was valued at USD 1 billion in 2015.
Bone Marrow Collection Needles:
Bone marrow collection needles are used for the withdrawal of bone marrow from the bones. The process is done to obtain stem cells which are then used in various research and diagnostic applications.
Application Insights:
Based on the application, the global market is segmented into hospital, clinic and diagnostic laboratories. The hospital segment dominated the market in 2017 owing to increasing number of stem cell transplant procedures globally. According to data published by International Society on Stem Cell Research (ISSCR), in 2016, over 150 thousand patients are living with blood disorders and another 200 thousand people are suffering from genetic diseases due to low birth rate and infertility worldwide. Thus, rising adoption of advanced technologies for regenerative medicine is expected to drive demand for stem cell concentration systems over the forecast period.
Clinical trials accounted for a significant share in revenue generation in 2017 owing to increasing R&D initiatives by various biopharmaceutical companies for developing new drugs using adult stem cells or induced pluripotent stem cells (iPSCs). For instance, Amgen Inc.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in the number of clinical trials and increasing government funding for stem cell research. Moreover, an increase in sports injuries and road accidents has led to an increased demand for stromal cell-based therapy. The availability of reimbursement facilities also contributes to its large share.
Asia Pacific is expected to witness lucrative growth over the forecast period due to factors such as rising healthcare expenditure, high unmet medical needs coupled with growing awareness about emerging therapies especially adult Stem Cell Therapy (AST). Increasing investments by private companies are also anticipated fuel regional growth during the forecast period. For instance, Novo Nordisk along with collaborating universities have initiated a new initiative “Novonordisk University Research Alliance†which focuses on diabetes research through human embryonic stem cells (HESC). Such initiatives are expected drive regional demand during the forecast period.
Growth Factors:
- Increasing demand for stem cell therapies for various diseases is driving the growth of the stem cell concentration system market.
- Rising number of stem cell research and clinical trials is also propelling the growth of this market.
- Growing investments by private and public organizations in stem cell research are fueling the demand for advanced concentration systems.
- Technological advancements in concentration systems are providing new opportunities to this market’s players.
- increasing awareness about benefits of stem cells therapies is encouraging people to use these therapies, thereby driving the growth of this market
Scope Of The Report
Report Attributes
Report Details
Report Title
Stem Cell Concentration System Market Research Report
By Type
Syringes, Bone Marrow Collection Needles, Anticoagulant and Concentrating Devices, Others
By Application
Hospital, Clinic, Diagnostic Laboratories
By Companies
EmCyte, Zimmer Biomet, Argos Technologies, Perkin Elmer, Arthrex, Avita Medical, Teleflex, Terumo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
204
Number of Tables & Figures
143
Customization Available
Yes, the report can be customized as per your need.
Global Stem Cell Concentration System Market Report Segments:
The global Stem Cell Concentration System market is segmented on the basis of:
Types
Syringes, Bone Marrow Collection Needles, Anticoagulant and Concentrating Devices, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Diagnostic Laboratories
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- EmCyte
- Zimmer Biomet
- Argos Technologies
- Perkin Elmer
- Arthrex
- Avita Medical
- Teleflex
- Terumo
Highlights of The Stem Cell Concentration System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Syringes
- Bone Marrow Collection Needles
- Anticoagulant and Concentrating Devices
- Others
- By Application:
- Hospital
- Clinic
- Diagnostic Laboratories
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Stem Cell Concentration System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A stem cell concentration system is a device that helps to increase the concentration of stem cells. This can be helpful in research, as it allows for more accurate measurements of the number and type of stem cells present.
Some of the key players operating in the stem cell concentration system market are EmCyte, Zimmer Biomet, Argos Technologies, Perkin Elmer, Arthrex, Avita Medical, Teleflex, Terumo.
The stem cell concentration system market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Stem Cell Concentration System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Stem Cell Concentration System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Stem Cell Concentration System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Stem Cell Concentration System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Stem Cell Concentration System Market Size & Forecast, 2020-2028
4.5.1 Stem Cell Concentration System Market Size and Y-o-Y Growth
4.5.2 Stem Cell Concentration System Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Syringes
5.2.2 Bone Marrow Collection Needles
5.2.3 Anticoagulant and Concentrating Devices
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Diagnostic Laboratories
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Stem Cell Concentration System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Stem Cell Concentration System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Syringes
9.6.2 Bone Marrow Collection Needles
9.6.3 Anticoagulant and Concentrating Devices
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.10.3 Diagnostic Laboratories
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Syringes
10.6.2 Bone Marrow Collection Needles
10.6.3 Anticoagulant and Concentrating Devices
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.10.3 Diagnostic Laboratories
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Syringes
11.6.2 Bone Marrow Collection Needles
11.6.3 Anticoagulant and Concentrating Devices
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.10.3 Diagnostic Laboratories
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Syringes
12.6.2 Bone Marrow Collection Needles
12.6.3 Anticoagulant and Concentrating Devices
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.10.3 Diagnostic Laboratories
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Syringes
13.6.2 Bone Marrow Collection Needles
13.6.3 Anticoagulant and Concentrating Devices
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.10.3 Diagnostic Laboratories
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Stem Cell Concentration System Market: Competitive Dashboard
14.2 Global Stem Cell Concentration System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 EmCyte
14.3.2 Zimmer Biomet
14.3.3 Argos Technologies
14.3.4 Perkin Elmer
14.3.5 Arthrex
14.3.6 Avita Medical
14.3.7 Teleflex
14.3.8 Terumo
